Presence of the Inflammatory Cytokines IL-1, TNF, and IL-6 in Preparations of Monoclonal Antibodies
- 1 June 1989
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 8 (3) , 361-367
- https://doi.org/10.1089/hyb.1989.8.361
Abstract
We have detected significant levels of IL-1, TNF and IL-6 in ascitic fluid from mice injected with different hybridomas. Each of these murine cytokines is active on a wide range of both human and murine target cells, and all are involved in inflammatory responses in vivo. We could not detect TNF or IL-1 in culture supernatant from the hybridoma line, used to generate the ascites; however, one out of ten did produce high levels of IL-6. These cytokines can interfere in many in vitro systems where monoclonal antibodies are used as diluted ascitic fluid to inhibit their ligands. A potentially more serious problem could arise with monoclonal antibodies used for therapy, in vivo diagnosis, or as ex vivo reagents. The use of monoclonal antibodies derived from culture supernatants is, therefore, obviously preferable to use of ascitic fluid for clinical applications, however, even with supernatant it cannot be assumed that cytokines are not present. Cytokine levels should, therefore, be monitored in all starting solutions and if present, their clearance during purification should be determined.This publication has 5 references indexed in Scilit:
- Functional discrimination between interleukin 6 and interleukin 1European Journal of Immunology, 1988
- SENSITIVE AND SPECIFIC IMMUNORADIOMETRIC ASSAYS FOR HUMAN INTERLEUKIN-1-ALPHA1988
- A simple sensitive bioassay for interleukin-1 which is unresponsive to 103 U/ml of interleukin-2Journal of Immunological Methods, 1987
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytesJournal of Immunological Methods, 1986
- An improved colorimetric assay for interleukin 2Journal of Immunological Methods, 1986